FindTrial
Sign In

Role of umbilical cord blood transfusion in neonates with birth asphyxia

Impact of umbilical cord blood transfusion in outcome of patients with birth asphyxia - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/05/087972
Enrollment
100
Registered
2025-05-30
Start date
Unknown
Completion date
Unknown
Last updated
2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: P916- Hypoxic ischemic encephalopathy [HIE]

Interventions

Intervention1: Umbilical cord blood: Umbilical cord blood given to birth asphyxia patient and follow up between 3 to 6 months Control Intervention1: Adult blood transfusion: Adult blood transfusion in

Sponsors

Vineet Singh Gaharwar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Term neonates with perinatal asphyxia with 1 minute APGAR score less than 5/10

Exclusion criteria

Exclusion criteria: 1. Septicemia 2. RH incompatibility 3. Chorioamnionitis 4. Intra uterine growth restriction 5. Mothers on medications that change blood profile 6. Newborns with severe congenital malformation 7. Chromosomal anomalies 8. Maternal diabetes mellitus 9. Multiple gestation

Design outcomes

Primary

MeasureTime frame
HNNE, HINETimepoint: On discharge, 3 months and 6 months—

Secondary

MeasureTime frame
NILTimepoint: NIL—

Countries

India

Contacts

Public ContactVineet singh gaharwar

Shyam Shah Medical College

naresh30405@gmail.com9399372171

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026